Introduction: Diabetic patients have poorer short-term outcome after coronary artery surgery [1] . It has been suggested that preoperative HbA1c may predict length of stay in such patients [2] . The aim of this study was to find out the impact of long-term glycaemic control expressed by preoperative HbA1c on perioperative outcome in diabetic patients following coronary artery surgery. Method: 145 consecutive diabetic patients underwent first-time coronary artery surgery in a period of 11 months and had their HbA1c assessed Results: Fifty-nine percent of the patients had low plasma AT III levels before CPB (levels Ͻ80%). Of these, 64% required the administration of AT III concentrate for correct anticoagulation to be attained, since the mean ACT after the first dose of heparin was 404 seconds. In 37.5% of the cases, the patients received 500 U of AT III; 12.5% 750 U of AT III, and 50% 1000 U of AT III. Conclusions: We consider that a low pre-operative plasma AT III level predicts and an ACT value lower than 480 seconds after heparin indicates resistance to heparin and the need to administer AT III concentrate to achieve correct anticoagulation during CPB. The optimum dose of AT III concentrate in cases of heparin resistance is 1000 U.
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Continuous thrombin generation for monitoring phenprocoumon anticoagulation Emory University School of Medicine, Atlanta, Georgia, United States, 2 ZLB Behring GmbH, Marburg, Germany Introduction: Phenprocoumon (Phen) therapy is usually monitored with prothrombin time (PT), but the total amount of generated thrombin is not reflected in this test. Because a thrombin generation (TG) test is currently available (Thrombinoscope, Synapse BV, Netherlands), we hypothesized that TG measurement may be better suited for monitoring phenprocoumon anticoagulation and its reversal with prothrombin complex concentrate (PCC, Beriplex P/N, ZLB Behring, Marburg, Germany).
Method:
After the study was approved by the local ethics committee, rats in Group 1 received a single oral dose (2.5 mg/kg) of phenprocoumon (Marcumar, Grenzach-Wyhlen, Germany); Group 2 received the same treatment as Group 1 plus 50 U/kg of intravenous PCC at 15.75 h after phenprocoumon; Group 3 served as control. Blood samples were drawn at 16.00 h, and plasma was obtained by centrifugation. PT in sec was measured in plasma using Neoplastine CI plus kit and STart 4 instrument (Diagnostica Stago, Asnieres, France). For thrombin generation, the assay method of Hemker was followed [1] . Results: TG assay showed a decreased peak and total thrombin ( Fig. 1a ) and phenprocoumon prolonged the PT (Fig. 1b ). Treatment with PCC reversed the anticoagulation parameters toward control values. Conclusion: TG assay can monitor anticoagulation and reversal of coumarin type drugs allowing for a more complete coagulation profile than PT testing. Reference: 
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Introduction: Thromboelastography ( TEG) is used to evaluate the viscoelastic properties of whole blood. Citrated blood has been used after recalcification when the blood cannot be analysed immediately [1] [2] [3] . In this study we assessed the reliability of TEG analysis performed on citrated blood compared to fresh blood at various time intervals (1, 2 and 3 h) using fresh, native blood, and activated (kaolin and tissue factor) samples. Method: After Research Ethics Board approval, 10 healthy volunteers were enrolled for the study. Using TEG technology, measurements were obtained by analysing the fresh blood immediately and citrated blood at 1, 2 and 3 h after collection. The reaction time (r), k time (K), alpha angle (␣) and maximum amplitude (MA) were measured from each TEG tracing for native and activated (kaolin and tissue factor) blood samples.
Results:
The results of TEG analysis of fresh and citrated blood were different. In citrated native samples at 1, 2 and 3 hours the r and K values were significantly lower whereas the alpha angle and MA values were significantly higher than the fresh blood. Comparison of activated thromboelastogram values to native values at baseline show significantly shorter r and K values and greater MA values in the tissue factor activated samples. The differences among values obtained at 1, 2 and 3 h after citration were not statistically significant. Discussion: Citrate storage of the whole blood offers stable and repeatable conditions for TEG measurements from 1 to 3 h of storage. Additionally, citrate storage of native and TF activated whole blood "accelerates" the coagulation process by lowering r and K times, and increasing the value of alpha angle and MA. It is of importance to be aware of this phenomenon during clinical decision-making. These findings are in agreement with those of others and there are several possible explanations for the relative hypercoagulability of citrate stored samples. Camenzind et al. postulated that the relative hypercoagulability of the citrated blood is due to incomplete inhibition of thrombin formation by citrate. However, the important point is not aetiology of the hypercoagulable state but an awareness of the storageinduced hypercoagulability when interpreting TEG results obtained with blood stored with citrate, so that TEG results are not misinterpreted.
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